Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis : Focus on Therapy Type, Offering, Process, Technology, Application, and Region - Analysis and Forecast, 2023-2033

Table of Contents

1. Markets

• 1.1. Product Definition
  • 1.1.1. Product Definition
  • 1.1.2. Inclusion and Exclusion Criteria
• 1.2. Market Scope
  • 1.2.1. Scope of the Work
  • 1.2.2. Key Questions Answered in the Report
• 1.3. Research Methodology
  • 1.3.1. Global Cell and Gene Therapy Manufacturing QC Market
  • 1.3.2. Data Sources
    • 1.3.2.1. Primary Data Sources
    • 1.3.2.2. Secondary Data Sources
  • 1.3.3. Market Estimation Model
  • 1.3.4. Criteria for Company Profiling
• 1.4. Market Overview
  • 1.4.1. Global Market Scenario
    • 1.4.1.1. Realistic Growth Scenario
    • 1.4.1.2. Optimistic Scenario
    • 1.4.1.3. Pessimistic Scenario
  • 1.4.2. Market Footprint and Growth Potential
  • 1.4.3. Future Potential
  • 1.4.4. COVID-19 Impact on Market
    • 1.4.4.1. Impact on Research and Clinical Operations
    • 1.4.4.2. COVID-19 Impact: Current Scenario of the Market
    • 1.4.4.3. Pre- and Post-COVID-19 Impact Assessment
      • 1.4.4.3.1. Pre-COVID-19 Phase
      • 1.4.4.3.2. Post-COVID-19 Phase

2. Global Cell and Gene Therapy Manufacturing QC Market: Industry Analysis

• 2.1. Regulatory Framework
  • 2.1.1. Chemistry, Manufacturing, and Control (CMC) Requirements by the Food and Drug Administration (FDA)
    • 2.1.1.1. Product Testing
    • 2.1.1.2. Microbial Testing
    • 2.1.1.3. Identity
    • 2.1.1.4. Purity
    • 2.1.1.5. Potency
    • 2.1.1.6. Viability
    • 2.1.1.7. Cell Number or Dose
  • 2.1.2. Quality Aspects of Cell and Gene Therapy Products by the European Medicines Agency (EMA)
    • 2.1.2.1. Characterization
    • 2.1.2.2. Identity Testing
    • 2.1.2.3. Purity Testing
  • 2.1.3. Current Good Manufacturing Practice (CGMP) Regulations
    • 2.1.3.1. U.S.
    • 2.1.3.2. Europe
  • 2.1.4. Global Regulatory Framework: Cell and Gene Therapy Manufacturing QC Market

3. Global Cell and Gene Therapy Manufacturing QC Market: Market Dynamics

• 3.1. Overview
• 3.2. Impact Analysis
• 3.3. Market Drivers
  • 3.3.1. Growing Cell and Gene Therapy Production Leading to Increased Demand for Quality Control (QC)Testing
  • 3.3.2. Increasing Number of Approvals Leading to an Upsurge in Demand for Cell and Gene Therapies QC Testing
  • 3.3.3. Rise in Investment for the Development of Cell and Gene Therapies Increasing the Demand for QC Products and Services
• 3.4. Market Restraints
  • 3.4.1. Limited Adoption of Cell and Gene Therapy due to High Manufacturing and QC Costs
• 3.5. Market Opportunities
  • 3.5.1. Continuous Entry of New Market Participants in Cell and Gene Therapies to Create an Opportunity for the Expansion of Manufacturing Facilities and QC Testing Services
  • 3.5.2. Introduction of Technologically Advanced Products in QC Testing for Cell and Gene Therapies

4. Global Cell and Gene Therapy Manufacturing QC Market: Competitive Landscape

• 4.1. Overview
• 4.2. Key Strategies and Developments
  • 4.2.1. Synergistic Activities
  • 4.2.2. Product and Service Launches
  • 4.2.3. Mergers and Acquisitions
  • 4.2.4. Product Approvals
• 4.3. Market Share Analysis
• 4.4. Growth Share Analysis
  • 4.4.1. Growth Share Analysis (by Application)
• 4.5. Supply Chain Analysis
  • 4.5.1. Key Entities in Supply Chain

5. Global Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)

• 5.1. Overview
• 5.2. Cell Therapy
  • 5.2.1. Autologous
  • 5.2.2. Allogeneic
  • 5.2.3. Others
• 5.3. Gene Therapy
  • 5.3.1. Viral Vectors
  • 5.3.2. Non-Viral Vectors

6. Global Cell and Gene Therapy Manufacturing QC Market (by Offering)

• 6.1. Overview
• 6.2. Products
  • 6.2.1. Consumables
    • 6.2.1.1. Kits and Assays
    • 6.2.1.2. Reagents
    • 6.2.1.3. Cell Culture Media and Supplements
  • 6.2.2. Instruments
    • 6.2.2.1. Bioreactors/Fermenters
    • 6.2.2.2. PCR Systems
    • 6.2.2.3. Chromatography System
    • 6.2.2.4. Others
  • 6.2.3. Software
• 6.3. Services
  • 6.3.1. Safety Testing
  • 6.3.2. Potency Testing
  • 6.3.3. Identity Testing
  • 6.3.4. Stability and Genetic Fidelity Testing
  • 6.3.5. Others

7. Global Cell and Gene Therapy Manufacturing QC Market (by Process)

• 7.1. Overview
• 7.2. Raw Material Preparation
• 7.3. Upstream Processing
• 7.4. Downstream Processing
• 7.5. Packaging

8. Global Cell and Gene Therapy Manufacturing QC Market (by Technology)

• 8.1. Overview
• 8.2. Polymerase Chain Reaction (PCR)
• 8.3. Flow Cytometry
• 8.4. Limulus Amebocyte Lysate (LAL)
• 8.5. Enzyme-Linked Immunosorbent Assay (ELISA)
• 8.6. Chromatography
• 8.7. Mass Spectrometry
• 8.8. Western Blotting
• 8.9. Next-Generation Sequencing (NGS)
• 8.1. Electrophoresis
• 8.11. Other Technologies

9. Global Cell and Gene Therapy Manufacturing QC Market (by Application)

• 9.1. Overview
• 9.2. Safety Testing
  • 9.2.1. By Safety Testing Type
• 9.3. Potency Testing
  • 9.3.1. By Potency Testing Type
• 9.4. Identity Testing
  • 9.4.1. By Identity Testing Type
• 9.5. Stability and Genetic Fidelity Testing
  • 9.5.1. By Stability Testing and Genetic Fidelity Testing Type
• 9.6. Others

10. Global Cell and Gene Therapy Manufacturing QC Market (by Region)

• 10.1. Overview
• 10.2. North America
  • 10.2.1. North America Cell and Gene Therapy Manufacturing QC Market (by Offering)
  • 10.2.2. North America Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
  • 10.2.3. North America Cell and Gene Therapy Manufacturing QC Market (by Process)
  • 10.2.4. North America Cell and Gene Therapy Manufacturing QC Market (by Technology)
  • 10.2.5. North America Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.2.6. U.S.
    • 10.2.6.1. U.S. Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.2.6.2. U.S. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.2.6.3. U.S. Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.2.6.4. U.S. Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.2.6.5. U.S. Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.2.7. Canada
    • 10.2.7.1. Canada Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.2.7.2. Canada Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.2.7.3. Canada Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.2.7.4. Canada Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.2.7.5. Canada Cell and Gene Therapy Manufacturing QC Market (by Application)
• 10.3. Europe
  • 10.3.1. Europe Cell and Gene Therapy Manufacturing QC Market (by Offering)
  • 10.3.2. Europe Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
  • 10.3.3. Europe Cell and Gene Therapy Manufacturing QC Market (by Process)
  • 10.3.4. Europe Cell and Gene Therapy Manufacturing QC Market (by Technology)
  • 10.3.5. Europe Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.3.6. U.K.
    • 10.3.6.1. U.K. Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.3.6.2. U.K. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.3.6.3. U.K. Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.3.6.4. U.K. Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.3.6.5. U.K. Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.3.7. Germany
    • 10.3.7.1. Germany Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.3.7.2. Germany Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.3.7.3. Germany Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.3.7.4. Germany Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.3.7.5. Germany Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.3.8. France
    • 10.3.8.1. France Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.3.8.2. France Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.3.8.3. France Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.3.8.4. France Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.3.8.5. France Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.3.9. Italy
    • 10.3.9.1. Italy Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.3.9.2. Italy Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.3.9.3. Italy Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.3.9.4. Italy Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.3.9.5. Italy Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.3.10. Spain
    • 10.3.10.1. Spain Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.3.10.2. Spain Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.3.10.3. Spain Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.3.10.4. Spain Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.3.10.5. Spain Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.3.11. Rest-of-Europe
    • 10.3.11.1. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.3.11.2. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.3.11.3. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.3.11.4. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.3.11.5. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Application)
• 10.4. Asia-Pacific
  • 10.4.1. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering)
  • 10.4.2. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
  • 10.4.3. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process)
  • 10.4.4. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology)
  • 10.4.5. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.4.6. China
    • 10.4.6.1. China Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.4.6.2. China Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.4.6.3. China Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.4.6.4. China Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.4.6.5. China Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.4.7. Japan
    • 10.4.7.1. Japan Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.4.7.2. Japan Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.4.7.3. Japan Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.4.7.4. Japan Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.4.7.5. Japan Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.4.8. South Korea
    • 10.4.8.1. South Korea Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.4.8.2. South Korea Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.4.8.3. South Korea Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.4.8.4. South Korea Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.4.8.5. South Korea Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.4.9. Australia
    • 10.4.9.1. Australia Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.4.9.2. Australia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.4.9.3. Australia Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.4.9.4. Australia Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.4.9.5. Australia Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.4.10. India
    • 10.4.10.1. India Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.4.10.2. India Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.4.10.3. India Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.4.10.4. India Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.4.10.5. India Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.4.11. Rest-of-Asia-Pacific
    • 10.4.11.1. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.4.11.2. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.4.11.3. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.4.11.4. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.4.11.5. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application)
• 10.5. Middle East and Africa
  • 10.5.1. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Offering)
  • 10.5.2. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
  • 10.5.3. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Process)
  • 10.5.4. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Technology)
  • 10.5.5. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.5.6. Israel
    • 10.5.6.1. Israel Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.5.6.2. Israel Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.5.6.3. Israel Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.5.6.4. Israel Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.5.6.5. Israel Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.5.7. Turkiye
    • 10.5.7.1. Turkiye Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.5.7.2. Turkiye Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.5.7.3. Turkiye Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.5.7.4. Turkiye Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.5.7.5. Turkiye Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.5.8. K.S.A.
    • 10.5.8.1. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.5.8.2. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.5.8.3. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.5.8.4. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.5.8.5. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.5.9. U.A.E.
    • 10.5.9.1. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.5.9.2. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.5.9.3. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.5.9.4. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.5.9.5. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.5.10. South Africa
    • 10.5.10.1. South Africa Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.5.10.2. South Africa Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.5.10.3. South Africa Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.5.10.4. South Africa Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.5.10.5. South Africa Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.5.11. Rest-of-Middle East and Africa
    • 10.5.11.1. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.5.11.2. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.5.11.3. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.5.11.4. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.5.11.5. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Application)
• 10.6. Latin America
  • 10.6.1. Latin America Cell and Gene Therapy Manufacturing QC Market (by Offering)
  • 10.6.2. Latin America Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
  • 10.6.3. Latin America Cell and Gene Therapy Manufacturing QC Market (by Process)
  • 10.6.4. Latin America Cell and Gene Therapy Manufacturing QC Market (by Technology)
  • 10.6.5. Latin America Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.6.6. Brazil
    • 10.6.6.1. Brazil Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.6.6.2. Brazil Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.6.6.3. Brazil Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.6.6.4. Brazil Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.6.6.5. Brazil Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.6.7. Mexico
    • 10.6.7.1. Mexico Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.6.7.2. Mexico Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.6.7.3. Mexico Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.6.7.4. Mexico Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.6.7.5. Mexico Cell and Gene Therapy Manufacturing QC Market (by Application)
  • 10.6.8. Rest-of-Latin America
    • 10.6.8.1. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Offering)
    • 10.6.8.2. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
    • 10.6.8.3. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Process)
    • 10.6.8.4. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Technology)
    • 10.6.8.5. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Application)

11. Company Profiles

• 11.1. Overview
• 11.2. Manufacturers
  • 11.2.1. Bio-Techne Corporation
    • 11.2.1.1. Company Overview
    • 11.2.1.2. Role of Bio-Techne Corporation in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.1.3. Key Competitors
    • 11.2.1.4. Financials
    • 11.2.1.5. Analyst Perspective
  • 11.2.2. bioMerieux SA
    • 11.2.2.1. Company Overview
    • 11.2.2.2. Role of bioMerieux SA in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.2.3. Key Competitors
    • 11.2.2.4. Financials
    • 11.2.2.5. Analyst Perspective
  • 11.2.3. Danaher. (Cytiva)
    • 11.2.3.1. Company Overview
    • 11.2.3.2. Role of Danaher. (Cytiva) in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.3.3. Key Competitors
    • 11.2.3.4. Financials
    • 11.2.3.5. Key Insights about the Financial Health of the Company
    • 11.2.3.6. Analyst Perspective
  • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.4.1. Company Overview
    • 11.2.4.2. Role of F. Hoffmann-La Roche Ltd in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.4.3. Key Competitors
    • 11.2.4.4. Financials
    • 11.2.4.5. Key Insights about the Financial Health of the Company
    • 11.2.4.6. Analyst Perspective
  • 11.2.5. Lonza.
    • 11.2.5.1. Company Overview
    • 11.2.5.2. Role of Lonza. in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.5.3. Key Competitors
    • 11.2.5.4. Financials
    • 11.2.5.5. Analyst Perspective
  • 11.2.6. Miltenyi Biotec B.V. & Co. KG
    • 11.2.6.1. Company Overview
    • 11.2.6.2. Role of Miltenyi Biotec B.V. & Co. KG in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.6.3. Key Competitors
    • 11.2.6.4. Analyst Perspective
  • 11.2.7. Sartorius AG
    • 11.2.7.1. Company Overview
    • 11.2.7.2. Role of Sartorius AG in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.7.3. Key Competitors
    • 11.2.7.4. Financials
    • 11.2.7.5. Analyst Perspective
  • 11.2.8. Thermo Fisher Scientific Inc.
    • 11.2.8.1. Company Overview
    • 11.2.8.2. Role of Thermo Fisher Scientific Inc. in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.8.3. Key Competitors
    • 11.2.8.4. Financials
    • 11.2.8.5. Key Insights about the Financial Health of the Company
    • 11.2.8.6. Analyst Perspective
  • 11.2.9. WuXi AppTec
    • 11.2.9.1. Company Overview
    • 11.2.9.2. Role of WuXi AppTec in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.2.9.3. Key Competitors
    • 11.2.9.4. Financials
    • 11.2.9.5. Analyst Perspective
• 11.3. Service
  • 11.3.1. AGC Biologics.
    • 11.3.1.1. Company Overview
    • 11.3.1.2. Role of AGC Biologics. in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.3.1.3. Key Competitors
    • 11.3.1.4. Analyst Perspective
  • 11.3.2. Charles River Laboratories International, Inc.
    • 11.3.2.1. Company Overview
    • 11.3.2.2. Role of Charles River Laboratories International, Inc. in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.3.2.3. Key Competitors
    • 11.3.2.4. Financials
    • 11.3.2.5. Analyst Perspective
  • 11.3.3. Catalent, Inc
    • 11.3.3.1. Company Overview
    • 11.3.3.2. Role of Catalent, Inc in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.3.3.3. Key Competitors
    • 11.3.3.4. Financials
    • 11.3.3.5. Analyst Perspective
  • 11.3.4. Eurofins Scientific
    • 11.3.4.1. Company Overview
    • 11.3.4.2. Role of Eurofins Scientific in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.3.4.3. Key Competitors
    • 11.3.4.4. Financials
    • 11.3.4.5. Analyst Perspective
  • 11.3.5. Merck KGaA
    • 11.3.5.1. Company Overview
    • 11.3.5.2. Role of Merck KGaA in the Global Cell and Gene Therapy Manufacturing QC Market
    • 11.3.5.3. Key Competitors
    • 11.3.5.4. Financials
    • 11.3.5.5. Analyst Perspective
• 11.4. Emerging Companies
  • 11.4.1. Applied StemCell, Inc.
  • 11.4.2. Vineti

List of Figures

• Figure 1:. Cell and Gene Therapy Manufacturing QC Market, $Billion, 2022-2033
• Figure 2:. Global Cell and Gene Therapy Manufacturing QC Market, Impact Analysis
• Figure 3:. Global Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), % Share, 2022 and 2033
• Figure 4:. Global Cell and Gene Therapy Manufacturing QC Market (by Offering), % Share, 2022 and 2033
• Figure 5:. Global Cell and Gene Therapy Manufacturing QC Market (by Process), % Share, 2022 and 2033
• Figure 6:. Global Cell and Gene Therapy Manufacturing QC Market (by Technology), % Share, 2022 and 2033
• Figure 7:. Global Cell and Gene Therapy Manufacturing QC Market (by Application), % Share, 2022 and 2033
• Figure 8:. Global Cell and Gene Therapy Manufacturing QC Market (by Region), Market Snapshot
• Figure 9:. Global Cell and Gene Therapy Manufacturing QC Market Segmentation
• Figure 10:. Global Cell and Gene Therapy Manufacturing QC Market: Research Methodology
• Figure 11:. Primary Research Methodology
• Figure 12:. Bottom-Up Approach (Segment-Wise Analysis)
• Figure 13:. Top-Down Approach (Segment-Wise Analysis)
• Figure 14:. Global Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Realistic Scenario), $Billion, 2022-2033
• Figure 15:. Global Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Optimistic Scenario), $Billion, 2022-2033
• Figure 16:. Global Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Pessimistic Scenario), $Billion, 2022-2033
• Figure 17:. Global Cell and Gene Therapy Manufacturing QC Market, $Billion, 2022-2033
• Figure 18:. Impact of COVID-19 on CGT Developmental Activities
• Figure 19:. Global Cell and Gene Therapy Manufacturing QC Market - Market Dynamics
• Figure 20:. U.S.FDA-Approved Cell and Gene Therapies, 2011-2022
• Figure 21:. Number of Cell and Gene Therapy Developers (by Region)
• Figure 22:. Share of Key Developments, January 2020-April 2023
• Figure 23:. Number of Product and Service Launches (by Company), January 2020 to April 2023
• Figure 24:. Market Share Analysis of the Global Cell and Gene Therapy Manufacturing QC Market (by Company), 2022
• Figure 25:. Growth Share Analysis for Global Cell and Gene Therapy Manufacturing QC Market (by Applications), 2022
• Figure 26:. Supply Chain Analysis
• Figure 27:. Global Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
• Figure 28:. Global Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), % Share, 2022 and 2033
• Figure 29:. Global Cell and Gene Therapy Manufacturing QC Market (Cell Therapy), $Billion, 2022-2033
• Figure 30:. Global Cell and Gene Therapy Manufacturing QC Market (Autologous), $Billion, 2022-2033
• Figure 31:. Global Cell and Gene Therapy Manufacturing QC Market (Allogeneic), $Billion, 2022-2033
• Figure 32:. Global Cell and Gene Therapy Manufacturing QC Market (Others), $Million, 2022-2033
• Figure 33:. Global Cell and Gene Therapy Manufacturing QC Market (Gene Therapy), $Billion, 2022-2033
• Figure 34:. Several Types of Viral Vectors Used in Gene Therapy
• Figure 35:. Global Cell and Gene Therapy Manufacturing QC Market (Viral Vectors), $Million, 2022-2033
• Figure 36:. Global Cell and Gene Therapy Manufacturing QC Market (Non-Viral Vectors), $Million, 2022-2033
• Figure 37:. Global Cell and Gene Therapy Manufacturing QC Market (by Offering)
• Figure 38:. Global Cell and Gene Therapy Manufacturing QC Market (by Offering), % Share, 2022 and 2033
• Figure 39:. Global Cell and Gene Therapy Manufacturing QC Market (Products), $Billion, 2022-2033
• Figure 40:. Global Cell and Gene Therapy Manufacturing QC Market (Products), % Share, 2022 and 2033
• Figure 41:. Global Cell and Gene Therapy Manufacturing QC Market (Consumables), $Million, 2022-2033
• Figure 42:. Global Cell and Gene Therapy Manufacturing QC Market (Kits and Assays), $Million, 2022-2033
• Figure 43:. Global Cell and Gene Therapy Manufacturing QC Market (Reagents), $Million, 2022-20333
• Figure 44:. Global Cell and Gene Therapy Manufacturing QC Market (Cell Culture Media), $Million, 2022-2033
• Figure 45:. Global Cell and Gene Therapy Manufacturing QC Market (Instruments), $Million, 2022-2033
• Figure 46:. Global Cell and Gene Therapy Manufacturing QC Market (Bioreactors/Fermenters), $Million, 2022-2033
• Figure 47:. Global Cell and Gene Therapy Manufacturing QC Market (PCR Systems), $Million, 2022-2033
• Figure 48:. Global Cell and Gene Therapy Manufacturing QC Market (Chromatography System), $Million, 2022-2033
• Figure 49:. Global Cell and Gene Therapy Manufacturing QC Market (Others), $Million, 2022-2033
• Figure 50:. Global Cell and Gene Therapy Manufacturing QC Market (Software), $Million, 2022-2033
• Figure 51:. Global Cell and Gene Therapy Manufacturing QC Market (Services), $Billion, 2022-2033
• Figure 52:. Global Cell and Gene Therapy Manufacturing QC Market (Services), % Share, 2022 and 2033
• Figure 53:. Global Cell and Gene Therapy Manufacturing QC Market (Safety Testing), $ Billion, 2022-2033
• Figure 54:. Global Cell and Gene Therapy Manufacturing QC Market (Potency Testing), $Million, 2022-2033
• Figure 55:. Global Cell and Gene Therapy Manufacturing QC Market (Identity Testing), $Million, 2022-2033
• Figure 56:. Global Cell and Gene Therapy Manufacturing QC Market (Stability and Genetic Fidelity Testing), $Million, 2022-2033
• Figure 57:. Global Cell and Gene Therapy Manufacturing QC Market (Others), $Million, 2022-2033
• Figure 58:. Global Cell and Gene Therapy Manufacturing QC Market (by Process)
• Figure 59:. Global Cell and Gene Therapy Manufacturing QC Market (by Process), % Share, 2022-2033
• Figure 60:. Global Cell and Gene Therapy Manufacturing QC Market (Raw Material Preparation), $Million, 2022-2033
• Figure 61:. Followed Steps in Upstream Processing
• Figure 62:. Global Cell and Gene Therapy Manufacturing QC Market (Upstream Processing), $Billion, 2022-2033
• Figure 63:. Followed Steps in Downstream Processing
• Figure 64:. Global Cell and Gene Therapy Manufacturing QC Market (Downstream Processing), $Billion, 2022-2033
• Figure 65:. Steps Involved in Packaging Operations
• Figure 66:. Global Cell and Gene Therapy Manufacturing QC Market (Packaging), $Million, 2022-2033
• Figure 67:. Global Cell and Gene Therapy Manufacturing QC Market (by Technology)
• Figure 68:. Global Cell and Gene Therapy Manufacturing QC Market (by Technology), % Share, 2022 and 2033
• Figure 69:. Global Cell and Gene Therapy Manufacturing QC Market (PCR), $Million, 2022-2033
• Figure 70:. Global Cell and Gene Therapy Manufacturing QC Market (Flow Cytometry), $Million,2022-2033
• Figure 71:. Global Cell and Gene Therapy Manufacturing QC Market (LAL), $Million,2022-2033
• Figure 72:. Global Cell and Gene Therapy Manufacturing QC Market (ELISA), $Million, 2022-2033
• Figure 73:. Global Cell and Gene Therapy Manufacturing QC Market (Chromatography), $Million, 2022-2033
• Figure 74:. Global Cell and Gene Therapy Manufacturing QC Market (Mass Spectrometry), $Million, 2022-2033
• Figure 75:. Global Cell and Gene Therapy Manufacturing QC Market (Western Blotting), $Million, 2022-2033
• Figure 76:. Global Cell and Gene Therapy Manufacturing QC Market (NGS), $Million, 2022-2033
• Figure 77:. Global Cell and Gene Therapy Manufacturing QC Market (Electrophoresis), $Million, 2022-2033
• Figure 78:. Global Cell and Gene Therapy Manufacturing QC Market (Other Technologies), $Million, 2022-2033
• Figure 79:. Global Cell and Gene Therapy Manufacturing QC Market (by Application)
• Figure 80:. Global Cell and Gene Therapy Manufacturing QC Market (by Application), % Share, 2022 and 2033
• Figure 81:. Global Cell and Gene Therapy Manufacturing QC Market (Safety Testing), $Billion, 2022-2033
• Figure 82:. Global Cell and Gene Therapy Manufacturing QC Market (by Safety Testing Type), % Share, 2022 and 2033
• Figure 83:. Global Cell and Gene Therapy Manufacturing QC Market (Potency Testing), $Million, 2022-2033
• Figure 84:. Global Cell and Gene Therapy Manufacturing QC Market (by Potency Testing Type), % Share, 2022 and 2033
• Figure 85:. Global Cell and Gene Therapy Manufacturing QC Market (Identity Testing), $Million, 2022-2033
• Figure 86:. Global Cell and Gene Therapy Manufacturing QC Market (by Identity Testing Type), % Share, 2022 and 2033
• Figure 87:. Global Cell and Gene Therapy Manufacturing QC Market (Stability and Genetic Fidelity Testing), $Million, 2022-2033
• Figure 88:. Global Cell and Gene Therapy Manufacturing QC Market (by Identity Testing Type), % Share, 2022 and 2033
• Figure 89:. Global Cell and Gene Therapy Manufacturing QC Market (Others), $Million, 2022-2033
• Figure 90:. Global Cell and Gene Therapy Manufacturing QC Market (by Region), Market Snapshot
• Figure 91:. North America Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 92:. North America Cell and Gene Therapy Manufacturing QC Market (by Country), % Share, 2022 and 2033
• Figure 93:. North America Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 94:. North America Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 95:. North America Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 96:. North America Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 97:. North America Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 98:. U.S. Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 99:. U.S. Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 100:. U.S. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 101:. U.S. Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 102:. U.S. Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 103:. U.S. Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 104:. Canada Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 105:. Canada Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 106:. Canada Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 107:. Canada Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 108:. Canada Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 109:. Canada Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 110:. Europe Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 111:. Europe Cell and Gene Therapy Manufacturing QC Market (by Country), % Share, 2022-2033
• Figure 112:. Europe Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 113:. Europe Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 114:. Europe Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 115:. Europe Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 116:. Europe Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 117:. U.K. Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 118:. U.K. Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 119:. U.K. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 120:. U.K. Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 121:. U.K. Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 122:. U.K. Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 123:. Germany Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 124:. Germany Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 125:. Germany Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 126:. Germany Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 127:. Germany Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 128:. Germany Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 129:. France Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 130:. France Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 131:. France Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 132:. France Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 133:. France Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 134:. France Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 135:. Italy Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 136:. Italy Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 137:. Italy Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 138:. Italy Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 139:. Italy Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 140:. Italy Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 141:. Spain Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 142:. Spain Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 143:. Spain Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 144:. Spain Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 145:. Spain Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 146:. Spain Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 147:. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 148:. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 149:. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 150:. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 151:. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 152:. Rest-of-Europe Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 153:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 154:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Country), % Share, 2022-2033
• Figure 155:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 156:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 157:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 158:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 159:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 160:. China Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 161:. China Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 162:. China Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 163:. China Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 164:. China Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 165:. China Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 166:. Japan Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 167:. Japan Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 168:. Japan Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 169:. Japan Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 170:. Japan Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 171:. Japan Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 172:. South Korea Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 173:. South Korea Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 174:. South Korea Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 175:. South Korea Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 176:. South Korea Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 177:. South Korea Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 178:. Australia Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 179:. Australia Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 180:. Australia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 181:. Australia Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 182:. Australia Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 183:. Australia Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 184:. India Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 185:. India Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 186:. India Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 187:. India Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 188:. India Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 189:. India Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 190:. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 191:. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 192:. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 193:. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 194:. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 195:. Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 196:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 197:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Country), % Share, 2022-2033
• Figure 198:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 199:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 200:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 201:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 202:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 203:. Israel Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 204:. Israel Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 205:. Israel Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 206:. Israel Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 207:. Israel Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 208:. Israel Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 209:. Türkiye Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 210:. Türkiye Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 211:. Türkiye Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 212:. Türkiye Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 213:. Türkiye Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 214:. Türkiye Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 215:. K.S.A. Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 216:. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 217:. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 218:. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 219:. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 220:. K.S.A. Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 221:. U.A.E. Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 222:. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 223:. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 224:. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 225:. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 226:. U.A.E. Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 227:. South Africa Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 228:. South Africa Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 229:. South Africa Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 230:. South Africa Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 231:. South Africa Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 232:. South Africa Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 233:. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 234:. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 235:. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 236:. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 237:. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 238:. Rest-of-Middle East and Africa Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 239:. Latin America Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 240:. Latin America Cell and Gene Therapy Manufacturing QC Market (by Country), % Share, 2022-2033
• Figure 241:. Latin America Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 242:. Latin America Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 243:. Latin America Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 244:. Latin America Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 245:. Latin America Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 246:. Brazil Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 247:. Brazil Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 248:. Brazil Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 249:. Brazil Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 250:. Brazil Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 251:. Brazil Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 252:. Mexico Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 253:. Mexico Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 254:. Mexico Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 255:. Mexico Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 256:. Mexico Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 257:. Mexico Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 258:. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market, $Million, 2022-2033
• Figure 259:. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2022-2033
• Figure 260:. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2022-2033
• Figure 261:. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2022-2033
• Figure 262:. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2022-2033
• Figure 263:. Rest-of-Latin America Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2022-2033
• Figure 264:. Total Number of Companies Profiled
• Figure 265:. Bio-Techne Corporation: Product Portfolio
• Figure 266:. Bio-Techne Corporation: Overall Financials, $Million, 2020-2022
• Figure 267:. Bio-Techne Corporation: Revenue (by Segment), $Million, 2020-2022
• Figure 268:. Bio-Techne Corporation: Revenue (by Region), $Million, 2020-2022
• Figure 269:. bioMérieux SA: Product Portfolio
• Figure 270:. bioMérieux SA: Overall Financials, $Million, 2020-2022
• Figure 271:. bioMérieux SA: Revenue (by Segment), $Million, 2020-2022
• Figure 272:. bioMérieux SA: Revenue (by Region), $Million, 2020-2022
• Figure 273:. Danaher. (Cytiva): Product Portfolio
• Figure 274:. Danaher. (Cytiva): Overall Financials, $Million, 2020-2022
• Figure 275:. Danaher. (Cytiva): Revenue (by Segment), $Million, 2020-2022
• Figure 276:. Danaher. (Cytiva): Revenue (by Region), $Million, 2020-2022
• Figure 277:. Danaher. (Cytiva): R&D Expenditure, $Million, 2019-2021
• Figure 278:. F. Hoffmann-La Roche Ltd: Product Portfolio
• Figure 279:. F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2020-2022
• Figure 280:. F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2020-2022
• Figure 281:. F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2020-2022
• Figure 282:. F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2020-2022
• Figure 283:. Lonza.: Product Portfolio
• Figure 284:. Lonza.: Overall Financials, $Million, 2020-2022
• Figure 285:. Lonza.: Revenue (by Segment), $Million, 2021and 2022
• Figure 286:. Miltenyi Biotec B.V. & Co. KG: Product Portfolio
• Figure 287:. Sartorius AG: Product Portfolio
• Figure 288:. Sartorius AG: Overall Financials, $Million, 2020-2022
• Figure 289:. Sartorius AG: Revenue (by Segment), $Million, 2020-2022
• Figure 290:. Sartorius AG: Revenue (by Region), $Million, 2020-2022
• Figure 291:. Thermo Fisher Scientific Inc.: Product Portfolio
• Figure 292:. Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
• Figure 293:. Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
• Figure 294:. Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
• Figure 295:. Thermo Fisher Scientific Inc.: R&D Expenditure, 2020-2022
• Figure 296:. WuXi AppTec: Product Portfolio
• Figure 297:. WuXi AppTec: Overall Financials, $Million, 2020-2022
• Figure 298:. WuXi AppTec: Revenue (by Segment), $Million, 2021 and 2022
• Figure 299:. AGC Biologics.: Product Portfolio
• Figure 300:. Charles River Laboratories International, Inc.: Product Portfolio
• Figure 301:. Charles River Laboratories International, Inc.: Overall Financials, $Million, 2020-2022
• Figure 302:. Charles River Laboratories International, Inc: Revenue (by Segment), $Million, 2020-2022
• Figure 303:. Charles River Laboratories International, Inc.: Revenue (by Region), $Million, 2020-2022
• Figure 304:. Catalent, Inc: Product Portfolio
• Figure 305:. Catalent, Inc: Overall Financials, $Million, 2020-2022
• Figure 306:. Catalent, Inc: Revenue (by Segment), $Million, 2020-2022
• Figure 307:. Catalent, Inc: Revenue (by Region), $Million, 2020-2022
• Figure 308:. Eurofins Scientific: Product Portfolio
• Figure 309:. Eurofins Scientific.: Overall Financials, $Million, 2020-2022
• Figure 310:. Eurofins Scientific.: Revenue (by Segment), $Million, 2020-2022
• Figure 311:. Eurofins Scientific.: Revenue (by Region), $Million, 2020-2022
• Figure 312:. Merck KGaA: Product Portfolio
• Figure 313:. Merck KGaA: Overall Financials, $Million, 2020-2022
• Figure 314:. Merck KGaA: Revenue (by Segment), $Million, 2020-2022
• Figure 315:. Merck KGaA: Revenue (by Region), $Million, 2020-2022

List of Tables

• Table 1:. Key Questions Answered in the Report
• Table 2:. Global Regulatory Scenario: Cell and Gene Therapy Manufacturing QC Market
• Table 3:. Impact Analysis, Market Drivers
• Table 4:. Investments in Cell and Gene Therapy Development, 2021-2022
• Table 5:. North America Cell and Gene Therapy Manufacturing QC Market, Impact Analysis
• Table 6:. Europe Cell and Gene Therapy Manufacturing QC Market Dynamics, Impact Analysis
• Table 7:. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Dynamics, Impact Analysis
• Table 8:. Approved Cell and Gene Therapies, Japan
• Table 9:. Latin America Cell and Gene Therapy Manufacturing QC Market Dynamics, Impact Analysis
• Table 10:. Middle East and Africa Cell and Gene Therapy Manufacturing QC Market Dynamics, Impact Analysis